PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
6.84
+0.14 (+2.09%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close6.70
Open6.73
Bid6.80 x 0
Ask6.81 x 0
Day's Range6.65 - 6.90
52 Week Range6.06 - 11.50
Volume133,162
Avg. Volume183,976
Market Cap659.666M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.37
Earnings DateJul 15, 2019 - Jul 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.88
  • CNW Group14 days ago

    IIROC Trading Resumption - PCLO

    IIROC Trading Resumption - PCLO

  • PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
    CNW Group14 days ago

    PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million

    TORONTO , June 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced that it has entered into a scheme implementation agreement (the "Implementation Agreement") pursuant to which PharmaCielo has agreed to acquire all of the issued and outstanding shares and listed options of Creso Pharma Ltd. ("Creso Pharma") (CPH.AX), for an aggregate purchase price of approximately A$122 million (the "Acquisition").  Creso Pharma is a global medicinal cannabis company that specializes in research, development and production of therapeutic, nutraceutical and animal health products. PharmaCielo will pay A$0.63 per Creso Pharma share, representing a premium of 50% over the closing trading price of the Creso Pharma shares on May 31 , 2019.

  • CNW Group14 days ago

    IIROC Trading Halt - PCLO

    IIROC Trading Halt - PCLO

  • PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
    PR Newswire22 days ago

    PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor

    TORONTO, May 29, 2019 /PRNewswire/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it has enlisted former U.S. congressman and long-time medical cannabis advocate Dana Rohrabacher as a special advisor to the Company.

  • PharmaCielo Announces its Financial Results for the First Quarter 2019
    CNW Group24 days ago

    PharmaCielo Announces its Financial Results for the First Quarter 2019

    TORONTO and RIONEGRO, Colombia , May 27, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced its financial results for the first quarter ended March 31, 2019 .

  • PharmaCielo Announces Results of AGM
    CNW Group27 days ago

    PharmaCielo Announces Results of AGM

    PharmaCielo Announces Results of AGM

  • Ups and Downs in the Cannabis Space Last Week
    Market Realist2 months ago

    Ups and Downs in the Cannabis Space Last Week

    Cannabis Updates: Price Action, Ratings, and MoreCannabis spaceThe cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively, while the

  • Cannabis Updates: New Listings, Price Action, and Ratings
    Market Realist2 months ago

    Cannabis Updates: New Listings, Price Action, and Ratings

    Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.

  • PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018
    CNW Group2 months ago

    PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018

    PharmaCielo expects to begin commercial sales in 2019. Oil processing facility is on track for commercial operation and GMP certification during Q3-2019, enabling large-scale production and sale of refined cannabis oil. Currently, 10 hectares are under active cultivation, expanding to 20 hectares (~2.15 million square feet) by year-end 2019, backed by 20 proprietary registered strains and 186 strains in the Company's germplasm bank.

  • Could The PharmaCielo Ltd. (CVE:PCLO) Ownership Structure Tell Us Something Useful?
    Simply Wall St.2 months ago

    Could The PharmaCielo Ltd. (CVE:PCLO) Ownership Structure Tell Us Something Useful?

    Every investor in PharmaCielo Ltd. (CVE:PCLO) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ow...

  • ACCESSWIRE2 months ago

    The Top 3 Cannabis Companies with a Focus on International Expansion

    In their report, "The Road Map to $57 Billion Worldwide Market," analysts note that the South American market for example could grow from $125 million in 2018 to $776 million by 2027. The Yield Growth Corporation (BOSS)(BOSQF) just entered into an agreement with Pontier Services to set up Urban Juve hemp beauty products for e-commerce sales in WeChat, in addition to launching a marketing campaign with AI-enabled pop-up kiosks to rotate through six major locations in Hong Kong beginning in June 2019. Such a move will establish Urban Juve as the first Canadian brand to launch Pop Square AI-enabled pop-up kiosks in China.

  • CNW Group2 months ago

    PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board

    TORONTO and RIONEGRO, Colombia , April 9, 2019 /CNW/ - David Attard , Chief Executive Officer of PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the appointment of the Company's extended Medical and Scientific Advisory Board (MSAB).

  • ACCESSWIRE3 months ago

    Cannabis Companies are Just Beginning to Expand Global Footprint

    HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics. In their report, ...

  • CNW Group3 months ago

    PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration

    TORONTO and RIONEGRO, COLOMBIA , March 29, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received from the national cultivar registry approval for the listing of a further 10 strains, each of which has a prominent tetrahydrocannabinol (THC) profile. The additional registration of the new strains to the national cultivar registry, including a unique 1:1 THC to CBD ratio strain, doubles the number of approved strains PharmaCielo holds in the registry, making it the largest holder of approved strains in Colombia .

  • Market Exclusive3 months ago

    PharmaCielo Becomes 1st Colombia’s Cannabis Producer to Earn ISO Certification

    PharmaCielo Ltd. (OTCMKTS:PHCEF), which owns Colombia's based medicinal-grade cannabis oil cultivator and producer PharmaCielo Colombia Holdings S.A.S., said that they have received the ISO 9001:2015 certification for its cultivation and extraction operations. ISO 9001 is the international standard that specifies requirements for a quality management system. Organizations use the standard to show their ability to […]The post PharmaCielo Becomes 1st Colombia's Cannabis Producer to Earn ISO Certification appeared first on Market Exclusive.

  • Market Exclusive3 months ago

    Cannabis Stock News Daily Roundup March 19

    Canopy Growth (TSX: WEED) (NYSE: CGC) and OG DNA Genetics have signed an new partnership agreement. Under the terms of the agreement, the companies will work together to expand into global markets, including Europe. GB Sciences (OTCQB: GBLX) launched a Canada-based cannabinoid medicine company GBS Global Biopharma. The company will develop cannabinoid medicines for medical […]The post Cannabis Stock News Daily Roundup March 19 appeared first on Market Exclusive.

  • PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia
    CNW Group3 months ago

    PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia

    TORONTO and RIONEGRO, Colombia , March 19, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the Company has received the ISO 9001:2015 certification for its cultivation and extraction operations.

  • CNW Group3 months ago

    Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF

    Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF

  • ACCESSWIRE4 months ago

    Top 3 Cannabis Stocks Higher on Colombian Growth Story

    HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. "Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment," noted The Globe and Mail. Blueberries Medical Corp. (BBM), for example, just entered into a letter of intent for a joint venture with Harmony and Life S.A.S., operating as El Manantial medical centers.

  • Benzinga4 months ago

    Colombia Authorizes First Cannabis Export To Canada: 'This Event Has Been Two Years In The Making'

    In one of the most anticipated moves in the international cannabis space, Colombia is set to begin exporting cannabis to Canada. The first Colombian company to receive approval — from both Health Canada and the Colombian National Narcotics Fund — to export cannabis to Canada is Ecomedics S.A.S., doing business as Clever Leaves. Benzinga had the chance to discuss the move with Andres Fajardo, CEO of Clever Leaves.

  • CNW Group4 months ago

    PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains

    TORONTO and RIONEGRO, Colombia , Feb. 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received approval for the listing of 10 proprietary and unique tetrahydrocannabinol (THC) and cannabidiol (CBD) strains with the national cultivar registry. The Company can now proceed to commercial registration, production and sale of these strains within Colombia as well as for export to global markets.

  • PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
    CNW Group5 months ago

    PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico

    TORONTO and MEXICO CITY, MEXICO , Jan. 28, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (PCLO.V), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today its entry into the Mexican market through an equity joint venture (the "JV") with MINO Labs S.A. de C.V. ("MINO Labs"), a specialty pharmaceutical company and medical supply distributor based in Mexico , based on an agreement signed on January 25, 2019 . The JV is called PharmaCielo S.A. de C.V. ("PharmaCielo Mexico").